Cargando…
Osteonecrosis of the jaw in a male osteoporotic patient treated with denosumab
Osteonecrosis of the jaw (ONJ) is a clinical condition associated with long-term exposure to inhibitors of bone resorption, mainly bisphosphonates. Denosumab (DMab) is a human monoclonal antibody of the receptor activator of nuclear factor kappa-B ligand. It prevents osteoclast-mediated bone resorpt...
Autores principales: | Neuprez, A., Coste, S., Rompen, E., Crielaard, J. M., Reginster, J. Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889627/ https://www.ncbi.nlm.nih.gov/pubmed/23835864 http://dx.doi.org/10.1007/s00198-013-2437-z |
Ejemplares similares
-
Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019) -
Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022) -
Denosumab Related Osteonecrosis of Jaw: a Case Report
por: de Sales Lima, Marco Vinícius, et al.
Publicado: (2018) -
Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan
por: Liu, Fang-Chun, et al.
Publicado: (2023)